AI
NUVB icon

Acuitas Investments’s Nuvation Bio NUVB Stock Holding History

Acuitas Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-388,008
Closed -$889K – 102
2024
Q3 		$889K Buy
388,008
+22,267
+6% +$67.9K 0.4% 84
2024
Q2 		$1.07M Sell
365,741
-171,576
-32% -$524K 0.57% 67
2024
Q1 		$1.96M Buy
537,317
+76,846
+17% +$148K 0.99% 43
2023
Q4 		$661K Buy
460,471
+143,972
+45% +$185K 0.34% 89
2023
Q3 		$424K Sell
316,499
-18
-0% -$30 0.25% 90
2023
Q2 		$570K Buy
+316,517
New +$538K 0.33% 78

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Acuitas Investments's NUVB Position: Q4 2024 in Review

Acuitas Investments sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 388,008 shares — an estimated $889K sold.

Acuitas Investments first reported a position in NUVB in Q2 2023 and held it in 6 quarters. The position peaked at $1.96M in Q1 2024. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • Acuitas Investments reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • Acuitas Investments sold 388,008 Nuvation Bio shares in Q4 2024, an estimated $889K.
  • Acuitas Investments first reported a position in Nuvation Bio in Q2 2023 and held it in 6 quarters.
  • Acuitas Investments's Nuvation Bio position peaked at $1.96M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on Acuitas Investments's 13F filing for Q4 2024, filed 31 Jan 2025.